World’s biggest multibillionaire investor is buying THIS by the ton [picture]

Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.

Juan Jose Chacon-Quiros net worth and biography

Juan Chacon-Quiros Biography and Net Worth

Founder of Establishment Labs

Mr. Chacón-Quirós founded Establishment Labs in 2004, and has been a Director and Chief Executive Officer of Establishment Labs Holdings Inc. since its inception in 2013. Mr. Chacón Quirós has been involved in several sectors of the aesthetics industry, including serving for almost a decade as General Manager of an aesthetic medical device distribution business in Latin America and prior to that as Business Development Manager of a renowned plastic and reconstructive surgery clinic in Costa Rica. He has co-authored more than 45 patents that are helping advance the technology in areas like implants and surfaces, RFID and biosensors, 3D technology and surgical instruments development. He served as President of the Rugby Federation of Costa Rica from 2009 to 2015. Mr. Chacón-Quirós received his undergraduate degree from the Academie de Poitiers (economics) and attended the University of Massachusetts at Amherst. He holds the MIT Sloan Advanced Certificate for Executives (ACE) in Management, Innovation and Technology.

How do I contact Juan Jose Chacon-Quiros?: The corporate mailing address for Mr. Chacon-Quiros and other Establishment Labs executives is Building B15 and 25 Coyol Free Zone, Alajuela G2, . Establishment Labs can also be reached via phone at (062) 434-2400 and via email at [email protected]. Learn More on Juan Jose Chacon-Quiros' contact information.
Has Juan Jose Chacon-Quiros been buying or selling shares of Establishment Labs?: Juan Jose Chacon-Quiros has not been actively trading shares of Establishment Labs during the past quarter. Learn More on Juan Jose Chacon-Quiros' trading history.
Who are Establishment Labs' active insiders?: Establishment Labs' insider roster includes Juan Chacon-Quiros (Founder), Dennis Condon (Director), Roberto de Mezerville (CTO), Renee Gaeta (CFO), Lisa Gersh (Director), Nicholas Lewin (Director), and Edward Schutter (Director). Learn More on Establishment Labs' active insiders.
Are insiders buying or selling shares of Establishment Labs?: During the last twelve months, Establishment Labs insiders bought shares 3 times. They purchased a total of 9,250 shares worth more than $214,052.50. The most recent insider tranaction occured on December, 14th when Director Nicholas Sheridan Lewin bought 2,000 shares worth more than $54,080.00. Insiders at Establishment Labs own 11.4% of the company. Learn More about insider trades at Establishment Labs.
Information on this page was last updated on 12/14/2023.

Juan Jose Chacon-Quiros Insider Trading History at Establishment Labs

Juan Jose Chacon-Quiros Buying and Selling Activity at Establishment Labs

Establishment Labs Company Overview

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.

Today's Range

Now: $48.91

$45.92

$48.95

50 Day Range

MA: $47.78

$35.80

$55.38

2 Week Range

Now: $48.91

$16.96

$73.00

Volume

145,446 shs

Average Volume

423,688 shs

Market Capitalization

$1.34 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.24